Follow
Catalin Vlad
Catalin Vlad
Sef lucrari Disciplina Chirurgie si Ginecologie Oncologica, Departamentul Oncologie
Verified email at umfcluj.ro
Title
Cited by
Cited by
Year
The prognostic value of FOXP3+ T regulatory cells in colorectal cancer
C Vlad, P Kubelac, B Fetica, D Vlad, A Irimie, P Achimas-Cadariu
J buon 20 (1), 114-119, 2015
422015
The role of ketamine in the treatment of chronic cancer pain
AO Zgaia, A Irimie, D Sandesc, C Vlad, C Lisencu, A Rogobete, ...
Clujul Medical 88 (4), 457, 2015
352015
Tumor infiltrating lymphocytes as a prognostic factor in malignant melanoma. Review of the literature
VA Gata, CI Lisencu, CI Vlad, D Piciu, A Irimie, P Achimas-Cadariu
J. BUON 22 (3), 592-598, 2017
302017
The role of medical registries, potential applications and limitations
B Pop, B Fetica, ML Blaga, AP Trifa, P Achimas-Cadariu, CI Vlad, ...
Medicine and Pharmacy Reports 92 (1), 7, 2019
292019
Expression III: patients’ expectations and preferences regarding physician–patient relationship and clinical management—results of the international NOGGO/ENGOT-ov4-GCIG study …
G Oskay-Özcelik, S Alavi, R Richter, M Keller, R Chekerov, SC Cecere, ...
Annals of Oncology 29 (4), 910-916, 2018
212018
Current insights into the association of Nestin with tumor angiogenesis.
A Onisim, A Achimas-Cadariu, C Vlad, P Kubelac, P Achimas-Cadariu
angiogenesis 27 (20), 40, 2015
202015
The role of miRNA-31-3p and miR-31-5p in the anti-EGFR treatment efficacy of wild-type K-RAS metastatic colorectal cancer. Is it really the next best thing in miRNAs
D Sur, C Cainap, C Burz, A Havasi, IC Chis, C Vlad, V Milosevic, ...
J BUON 24 (5), 1739-1746, 2019
192019
Gastric cancer: adjuvant chemotherapy versus chemoradiation. A clinical point of view
C Cainap, C Vlad, A Seicean, O Balacescu, R Seicean, AM Constantin, ...
J BUON 24 (6), 2209-2219, 2019
182019
MiRNA-based therapeutics in oncology, realities, and challenges
O Balacescu, S Visan, O Baldasici, L Balacescu, C Vlad, ...
Antisense Ther, 2019
162019
Synthesis and antitumour evaluation of mono-and multinuclear [2+ 1] tricarbonylrhenium (I) complexes
D Giffard, E Fischer-Fodor, C Vlad, P Achimas-Cadariu, GS Smith
European Journal of Medicinal Chemistry 157, 773-781, 2018
162018
Evaluation of clinical, morphopathological and therapeutic prognostic factors in rectal cancer. Experience of a tertiary oncology center
C Vlad, P Kubelac, D Vlad, A Irimie, P Achimas Cadariu
J BUON 20 (1), 92-99, 2015
162015
The role of inhibitor of DNA-binding 1 (ID-1) protein and angiogenesis in serous ovarian cancer
MP Kubelac, B Fetica, IC VLAD, A Fulop, A Popa, P ACHIMAŞ-CADARIU
Anticancer Research 34 (1), 413-416, 2014
162014
Current and new predictors for treatment response in metastatic colorectal cancer. The role of circulating miRNAs as biomarkers
A Gherman, L Balacescu, S Gheorghe-Cetean, C Vlad, O Balacescu, ...
International journal of molecular sciences 21 (6), 2089, 2020
152020
The role of biomarkers and echocardiography in the evaluation of cardiotoxicity risk in children treated for leukemia
D Maniu, C Blag, G Popa, M Bota, C Vlad, C Cainap, O Balacescu, L Pop, ...
Morressier, 2017
152017
Expression of Nestin and CD133 in serous ovarian carcinoma
A Onisim, M Iancu, C Vlad, P Kubelac, B Fetica, A Fulop, ...
J BUON 21 (5), 1168-1175, 2016
132016
Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?
C Constantinescu, S Pasca, T Tat, P Teodorescu, C Vlad, S Iluta, D Dima, ...
Journal for ImmunoTherapy of Cancer 8 (1), 2020
122020
Expression of CDCP1 and ADAM12 in the ovarian cancer microenvironment
C Vlad, P Kubelac, A Onisim, B Fetica, A Fulop, A Irimie, ...
J buon 21 (4), 973-978, 2016
122016
The role of CDCP1 (CUB domain-containing protein 1) and ADAM12 (a disintegrin and metalloproteinase 12) in ovarian cancer
C Vlad, P Kubelac, A Onisim, A Irimie, P Achimas-Cadariu
J BUON 20 (3), 673-679, 2015
122015
The importance of ubiquitin E3 ligases, SCF and APC/C, in human cancers
OV Bochis, B Fetica, C Vlad, P Achimas-Cadariu, A Irimie
Clujul medical 88 (1), 9, 2015
122015
The clinical features associated with mutated BRCA1 and 2 genes in ovarian cancer patients
P Kubelac, C Vlad, I Berindan Neagoe, A Irimie, P Achimas Cadariu
J Buon 24 (4), 1538-1543, 2019
102019
The system can't perform the operation now. Try again later.
Articles 1–20